These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 38373419)

  • 21. Hepatitis B core-related antigen dynamics and risk of subsequent clinical relapses after nucleos(t)ide analog cessation.
    Tsai YN; Wu JL; Tseng CH; Chen TH; Wu YL; Chen CC; Fang YJ; Yang TH; Nguyen MH; Lin JT; Hsu YC
    Clin Mol Hepatol; 2024 Jan; 30(1):98-108. PubMed ID: 38092551
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomics on the road to functional cure of hepatitis B.
    Balagopal A; Thomas DL
    J Hepatol; 2024 Jan; 80(1):6-7. PubMed ID: 37984710
    [No Abstract]   [Full Text] [Related]  

  • 23. Moving toward hepatitis B virus functional cure - the impact of on-treatment kinetics of serum viral markers.
    Liang LY; Wong VW; Wong GL; Yip TC
    Clin Mol Hepatol; 2023 Jan; 29(1):113-117. PubMed ID: 36314042
    [No Abstract]   [Full Text] [Related]  

  • 24. Serum hepatitis B core-related antigen as a treatment predictor of pegylated interferon in patients with HBeAg-positive chronic hepatitis B.
    Chuaypen N; Posuwan N; Payungporn S; Tanaka Y; Shinkai N; Poovorawan Y; Tangkijvanich P
    Liver Int; 2016 Jun; 36(6):827-36. PubMed ID: 26678018
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Risk of Reactivation of Hepatitis B in Hepatitis B Surface Antigen-Negative and Hepatitis B Core Antigen Antibody Positive Patients Receiving Biologic Therapy.
    Gök Sargın Z
    Turk J Gastroenterol; 2023 Mar; 34(3):308-309. PubMed ID: 36919836
    [No Abstract]   [Full Text] [Related]  

  • 26. Why is the functional cure rate of young children with chronic hepatitis B receiving antiviral therapy considerably high?
    Wang FS; Li J; Zhang C
    Hepatol Int; 2024 Feb; 18(1):296-298. PubMed ID: 37907721
    [No Abstract]   [Full Text] [Related]  

  • 27. Combining Hepatitis B Virus RNA and Hepatitis B Core-Related Antigen: Guidance for Safely Stopping Nucleos(t)ide Analogues in Hepatitis B e Antigen-Positive Patients With Chronic Hepatitis B.
    Fan R; Peng J; Xie Q; Tan D; Xu M; Niu J; Wang H; Ren H; Chen X; Wang M; Sheng J; Tang H; Bai X; Wu Y; Zhou B; Sun J; Hou J;
    J Infect Dis; 2020 Jul; 222(4):611-618. PubMed ID: 32211776
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatitis B Core-Related Antigen: From Virology to Clinical Application.
    Lee HW; Ahn SH; Chan HL
    Semin Liver Dis; 2021 May; 41(2):182-190. PubMed ID: 33957693
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Serum hepatitis B core-related antigen as a surrogate marker of hepatitis B e antigen seroconversion in chronic hepatitis B.
    Chi XM; Wang XM; Wang ZF; Wu RH; Gao XZ; Xu HQ; Ding YH; Niu JQ
    World J Gastroenterol; 2021 Oct; 27(40):6927-6938. PubMed ID: 34790015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Hepatitis B core-related antigen reflects viral replication and protein production in chronic hepatitis B patients.
    Li J; Wu Z; Wang GQ; Zhao H
    Chin Med J (Engl); 2021 Mar; 134(10):1160-1167. PubMed ID: 33734135
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Posttreatment Hepatitis B Surface Antigen Seroreversion: The Bane of Combination Therapy in Chronic Hepatitis B?
    Sonneveld MJ; Brouwer WP; van der Meer AJ
    Gastroenterology; 2016 May; 150(5):1254-1255. PubMed ID: 27020333
    [No Abstract]   [Full Text] [Related]  

  • 32. Serum hepatitis B core-related antigen (HBcrAg) correlates with covalently closed circular DNA transcriptional activity in chronic hepatitis B patients.
    Testoni B; Lebossé F; Scholtes C; Berby F; Miaglia C; Subic M; Loglio A; Facchetti F; Lampertico P; Levrero M; Zoulim F
    J Hepatol; 2019 Apr; 70(4):615-625. PubMed ID: 30529504
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pregenomic HBV RNA and Hepatitis B Core-Related Antigen Predict Outcomes in Hepatitis B e Antigen-Negative Chronic Hepatitis B Patients Suppressed on Nucleos(T)ide Analogue Therapy.
    Carey I; Gersch J; Wang B; Moigboi C; Kuhns M; Cloherty G; Dusheiko G; Agarwal K
    Hepatology; 2020 Jul; 72(1):42-57. PubMed ID: 31701544
    [TBL] [Abstract][Full Text] [Related]  

  • 34. New biomarkers of hepatitis B virus (HBV) infection: HBV RNA and HBV core-related antigen, new kids on the block?
    Lim YS
    Clin Mol Hepatol; 2023 Jan; 29(1):118-119. PubMed ID: 36443925
    [No Abstract]   [Full Text] [Related]  

  • 35. KASL clinical practice guidelines for management of chronic hepatitis B.
    Korean Association for the Study of the Liver (KASL)
    Clin Mol Hepatol; 2019 Jun; 25(2):93-159. PubMed ID: 31185710
    [No Abstract]   [Full Text] [Related]  

  • 36. Human immunodeficiency virus coinfection differentially impacts hepatitis B virus viral markers based on hepatitis Be antigen status in patients with suppressed viremia.
    Lisker-Melman M; King WC; Ghany MG; Chung RT; Hinerman AS; Cloherty GA; Khalili M; Jain MK; Sulkowski M; Sterling RK
    J Viral Hepat; 2023 Aug; 30(8):700-709. PubMed ID: 37278302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A critique and systematic review of the clinical utility of hepatitis B core-related antigen.
    Adraneda C; Tan YC; Yeo EJ; Kew GS; Khakpoor A; Lim SG
    J Hepatol; 2023 Apr; 78(4):731-741. PubMed ID: 36586590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Three heads are better than two: Hepatitis B core-related antigen as a new predictor of hepatitis B virus-related hepatocellular carcinoma.
    Wu JW; Kao JH; Tseng TC
    Clin Mol Hepatol; 2021 Oct; 27(4):524-534. PubMed ID: 33618507
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Precore G1896A mutation is associated with reduced rates of HBsAg seroclearance in treated HIV hepatitis B virus co-infected patients from Western Africa.
    Boyd A; Moh R; Maylin S; Abdou Chekaraou M; Mahjoub N; Gabillard D; Anglaret X; Eholié SP; Delaugerre C; Danel C; Zoulim F; Lacombe K;
    J Viral Hepat; 2018 Oct; 25(10):1121-1131. PubMed ID: 29660214
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparison of hepatitis B virus core-related antigen and hepatitis B surface antigen for predicting HBeAg seroconversion in chronic hepatitis B patients with pegylated interferon therapy.
    Wang ML; Liao J; Wei B; Zhang DM; He M; Tao MC; Chen EQ; Tang H
    Infect Dis (Lond); 2018 Jul; 50(7):522-530. PubMed ID: 29463147
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.